IDEAS home Printed from https://ideas.repec.org/a/taf/ijecbs/v22y2015i2p231-243.html
   My bibliography  Save this article

Similar Products at Different Prices: Can Biopharmaceutical Companies Segment Markets?

Author

Listed:
  • Richard Manning
  • Christopher Stomberg
  • Benjamin Scher
  • Kathleen Twigg
  • Andrew Huson

Abstract

New data on Medicare Part B payments show provider-level utilization of two similar but distinct biologic medications used to treat wet age-related macular degeneration. Their interaction provides insight into the ability of manufacturers to effectively segment markets and suggests some analogies for the future interplay between originator biologics and biosimilars. In particular, most ophthalmologists administer a mix of Avastin (used off-label), Lucentis, and other drugs; only a small share exclusively choose Lucentis. This is inconsistent with the hypotheses that (1) the manufacturer is able to effectively segment the market, and (2) the major factor driving physicians' product choice is the financial motivation. The data are consistent with the notion that physicians typically exercise medical judgment on a patient-by-patient basis and that product choice is driven largely by factors other than simple financial interests. This raises important dynamic efficiency considerations regarding incentives for future biologic competition.

Suggested Citation

  • Richard Manning & Christopher Stomberg & Benjamin Scher & Kathleen Twigg & Andrew Huson, 2015. "Similar Products at Different Prices: Can Biopharmaceutical Companies Segment Markets?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 231-243, July.
    • Handle: RePEc:taf:ijecbs:v:22:y:2015:i:2:p:231-243
    DOI: 10.1080/13571516.2015.1045739
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1080/13571516.2015.1045739
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1080/13571516.2015.1045739?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:ijecbs:v:22:y:2015:i:2:p:231-243. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/CIJB20 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.